Assessing Novo Nordisk (NYSE:NVO) Valuation After Recent Weak Share Performance [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Event context and recent share performance Novo Nordisk (NYSE:NVO) has come back into focus for investors after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, and year to date. See our latest analysis for Novo Nordisk. At a share price of US$36.04, Novo Nordisk's recent 30 day share price return of a 3.77% decline and 1 year total shareholder return of a 47.69% decline suggest momentum has been fading rather than building. If you are weighing Novo Nordisk against other healthcare names, it can be useful to see what else is moving in the sector and compare with 33 healthcare AI stocks With a share price of US$36.04, single digit revenue and net income growth, and indications of a large intrinsic discount, is Novo Nordisk now trading below its underlying worth, or is the market already pricing in future growth? Most Popular Narrative: 62.1% Undervalued According to the most followed narrative on Novo Nordi
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Obesity drugmaker Kailera plans an IPO [Yahoo! Finance]Yahoo! Finance
- Mars CEO gets board role at GLP-1 supplier Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk (NVO) Shares Up Since Jim Cramer Said He Was A Buyer [Yahoo! Finance]Yahoo! Finance
- Stocks, sectors, and charts this strategist is watching [Yahoo! Finance]Yahoo! Finance
- 1 Reason This Biotech Stock Could Triple Before Year-End [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website